Close

More on MRSN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+65.4% Growth)
- Ratings (6.7 Score)

Upcoming Events

- Earnings (5/6/24)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mersana Therapeutics (NQ:MRSN)
Delayed: 2.85 -0.03 (1.04%)
Prev. Close $2.88  
Open$2.83 
52 Wk High$ 
52 Wk Low$ 
Day High$2.91 
Day Low$2.75 
P/E N/A  
EPS$ 
Volume1,996,373 

Friends, Peers and Foes (?): MRK (more...)

Apr 4, 2024 04:30 PM Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 3, 2024 08:15 PM Form 4 Mersana Therapeutics, For: Apr 01 Filed by: Alleva Lawrence M
Mar 19, 2024 02:06 AM JPMorgan Upgrades Mersana (MRSN) to Neutral, 'thinking through Expectations for Midyear B7-H4 Updates'
Feb 29, 2024 06:55 AM Mersana (MRSN) PT Raised to $5 at Baird
Feb 29, 2024 06:04 AM Wedbush Upgrades Mersana (MRSN) to Outperform
Feb 29, 2024 02:32 AM Guggenheim Upgrades Mersana (MRSN) to Buy
Feb 28, 2024 04:11 PM Form 8-K Mersana Therapeutics, For: Feb 28
Feb 28, 2024 04:11 PM Form 424B5 Mersana Therapeutics,
Feb 28, 2024 04:08 PM Form POS AM Mersana Therapeutics,
Feb 28, 2024 03:38 PM BTIG Upgrades Mersana (MRSN) to Buy
View All Articles

Entities mentioned with MRSN

View All Entities